- Medifast Inc (NYSE:MED) has entered into an accelerated share repurchase agreement (ASR) with JPMorgan Chase, National Association.
- Under the agreement, Medifast will repurchase an aggregate of $100 million of its common stock.
- The buyback equates to about 600,000 shares at the closing price on May 31, 2022, representing 5% of its outstanding stock.
- The company intends to fund the ASR program using available cash on hand and borrowings under its existing credit facility.
- Medifast held $122.1 million in cash and equivalents as of March 31, 2022.
- Price Action: MED shares are trading higher by 5.16% at $175.36 on the last check Wednesday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
Medifast Adopts $100M Accelerated Share Repurchase Program
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks